UTMD · Company research
Utah Medical Products Inc (UTMD): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Utah Medical Products extends tender offer for Utah Medical Products stock - ad-hoc-news.de | Utah Medical Products extends tender offer for Utah Medical Products stock ad-hoc-news.de | View source ↗ | ad-hoc-news.de | Oct 15, 2026 | neutral | 0 | 0.6 |
| Liquidity Mapping Around (UTMD) Price Events - Stock Traders Daily | Liquidity Mapping Around (UTMD) Price Events Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 14, 2026 | neutral | 0 | 0.6 |
| UTMD Trades at a Premium to the Industry: How to Play the Stock? | Utah Medical Products (UTMD) trades at a premium valuation of 4.05X EV/sales versus industry average of 2.68X. While the company benefits from strong margins (58.2% gross margin), a debt-free balance sheet with $87.5M in cash, and strategic acquisitions, it faces near-term headwinds including 12.3% revenue decline, major customer losses, and projected 10-13% revenue decline for 2026. Long-term investors may hold, but new investors should await a better entry point. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bearish | -0.333 | 1 |
| UTMD Trades at a Premium to the Industry: How to Play the Stock? | Utah Medical Products (UTMD) trades at a premium valuation of 4.05X EV/sales versus industry average of 2.68X. While the company benefits from strong margins (58.2% gross margin), a debt-free balance sheet with $87.5M in cash, and strategic acquisitions, it faces near-term headwinds including 12.3% revenue decline, major customer losses, and projected 10-13% revenue decline for 2026. Long-term investors may hold, but new investors should await a better entry point. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bearish | -0.333 | 1 |
| UTMD Trades at a Premium to the Industry: How to Play the Stock? - Yahoo! Finance Canada | UTMD Trades at a Premium to the Industry: How to Play the Stock? Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 8, 2026 | neutral | 0 | 0.6 |
| The $75-a-share tender offer at Utah Medical Products (UTMD) now expires October 27, 2026. - Stock Titan | The $75-a-share tender offer at Utah Medical Products (UTMD) now expires October 27, 2026. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Utah Medical Products (UTMD) Extends Stock Buyback Offer Deadline to October 27 - GuruFocus | Utah Medical Products (UTMD) Extends Stock Buyback Offer Deadline to October 27 GuruFocus | View source ↗ | GuruFocus | Oct 5, 2026 | neutral | 0 | 0.6 |
| Shareholders can consider Utah Medical’s results, scheduled for Oct. 22, before its $75 offer expires Oct. 27. - Stock Titan | Shareholders can consider Utah Medical’s results, scheduled for Oct. 22, before its $75 offer expires Oct. 27. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Trading Systems Reacting to (UTMD) Volatility - Stock Traders Daily | Trading Systems Reacting to (UTMD) Volatility Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 4, 2026 | neutral | 0 | 0.6 |
| At $75 a share, Utah Medical Products (UTMD) amends its offer to buy back stock. - Stock Titan | At $75 a share, Utah Medical Products (UTMD) amends its offer to buy back stock. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| A $75-a-share offer is scheduled to expire Wednesday, Oct. 7—not Tuesday. - Stock Titan | A $75-a-share offer is scheduled to expire Wednesday, Oct. 7—not Tuesday. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Utah Medical Products, Inc. Commences Tender Offer - TradingView | Utah Medical Products, Inc. Commences Tender Offer TradingView | View source ↗ | TradingView | Sep 24, 2026 | neutral | 0 | 0.6 |
| Utah Medical Products Says it's Prepared to Spend Nearly $49 Million to Repurchase ~20% of its Shares - Utah Money Watch | Utah Medical Products Says it's Prepared to Spend Nearly $49 Million to Repurchase ~20% of its Shares Utah Money Watch | View source ↗ | Utah Money Watch | Sep 22, 2026 | neutral | 0 | 0.6 |
| Utah Medical Products (UTMD) Slips Modestly as Shares Hold Above Key Support - Smart Money Flow Stocks - dars.gov.et | Utah Medical Products (UTMD) Slips Modestly as Shares Hold Above Key Support - Smart Money Flow Stocks dars.gov.et | View source ↗ | dars.gov.et | Sep 20, 2026 | neutral | 0 | 0.6 |
| Utah Medical Products (UTMD) Slips Modestly as Shares Hold Above Key Support - Diamond Pattern - dars.gov.et | Utah Medical Products (UTMD) Slips Modestly as Shares Hold Above Key Support - Diamond Pattern dars.gov.et | View source ↗ | dars.gov.et | Sep 20, 2026 | neutral | 0 | 0.6 |
| UTMD Announces Self-Tender for 20% of Its Shares - Yahoo Finance | UTMD Announces Self-Tender for 20% of Its Shares Yahoo Finance | View source ↗ | Yahoo Finance | Sep 15, 2026 | neutral | 0 | 0.6 |
| Utah Medical Products Expands Via Orion Medical Acquisition - The Globe and Mail | Utah Medical Products Expands Via Orion Medical Acquisition The Globe and Mail | View source ↗ | The Globe and Mail | Sep 1, 2026 | neutral | 0 | 0.6 |
| Utah Medical Products: Healthy Cash Holdings, But Declining Revenue Is A Cause For Concern - Seeking Alpha | Utah Medical Products: Healthy Cash Holdings, But Declining Revenue Is A Cause For Concern Seeking Alpha | View source ↗ | Seeking Alpha | Aug 26, 2026 | neutral | 0 | 0.6 |
| Utah Medical Products (UTMD) Stock Margins Slip To 29% Net Profit Challenging Bullish Narratives - Simply Wall Street | Utah Medical Products (UTMD) Stock Margins Slip To 29% Net Profit Challenging Bullish Narratives Simply Wall Street | View source ↗ | Simply Wall Street | Jul 25, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.